英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
personalis查看　personalis　在百度字典中的解释百度英翻中〔查看〕
personalis查看　personalis　在Google字典中的解释Google英翻中〔查看〕
personalis查看　personalis　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Personalis | Transforming the Active Management of Cancer
    Personalis is revolutionizing cancer care with combined expertise in advanced testing, cancer genomics, and data science Partner with us to unlock the potential of personalized treatments, drive groundbreaking innovations and better patient outcomes
  • Personalis | Personalizing Precision Oncology | Since 2011
    Personalis was founded in 2011 by a team of internationally-renowned next-generation sequencing (NGS) thought-leaders from Stanford University We’re committed to building a world where personalized testing provides greater confidence and exceptional outcomes for cancer patients
  • Accessioning Hub - Personalis
    Forgot Password? By logging in, you are agreeing to our Terms Conditions and Privacy Policy Need help? Contact support at
  • Personalis, Inc. - LinkedIn
    At Personalis, we are transforming the active management of cancer through breakthrough personalized testing We aim to drive a new paradigm for cancer management, guiding care from biopsy
  • Investor Relations | Personalis
    Personalis was founded in 2011 by a team of internationally-renowned next-generation sequencing (NGS) thought-leaders from Stanford University We’re committed to building a world where personalized testing provides greater confidence and exceptional outcomes for cancer patients
  • Personalis, Inc. (PSNL) - Yahoo Finance
    Find the latest Personalis, Inc (PSNL) stock quote, history, news and other vital information to help you with your stock trading and investing
  • News | Tempus AI, Inc.
    Tempus to Acquire Personalis, More Tightly Integrating Molecular Residual Disease (MRD) into Its AI-Enabled Precision Oncology Platform Tempus Highlights Landmark Publication Demonstrating Safe, Real-World Deployment of Paige Prostate AI Suite in the UK National Health Service Tempus to Report Second Quarter 2026 Financial Results on July 30
  • Contact - Personalis
    How can we help you?* We would also like to keep you updated via email with relevant industry insights, product solutions, and corporate updates Please indicate your marketing preference below: Add me to all marketing communications Monday – Friday 6 AM – 5 PM PST
  • Personalis | Precision Oncology Products for Clinicians
    Inform actionable treatment decisions, clinical trial matching and detect residual cancer at the earliest time via comprehensive genomic profiling
  • Personalis | Careers in Precision Oncology
    Personalis recognizes the rights related to personal information guaranteed by numerous states Personalis will fulfill its obligations with respect to valid requests to exercise these rights regardless of where in the U S you reside





中文字典-英文字典  2005-2009